← Back to Search

Omega-3 Nutritional Supplement

Omega-3 for Cataract

Phase 2 & 3
Waitlist Available
Led By Bradley Williams, MD
Research Sponsored by Physician Recommended Nutriceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This is a randomized, masked, placebo controlled study to assess the effect on visual acuity, if any, of the PRN omega-3 nutritional supplement in subjects undergoing cataract surgery.

Eligible Conditions
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Omega-3Active Control1 Intervention
re esterified TG omega-3
Group II: Safflower OilPlacebo Group1 Intervention
vegetable oil

Find a Location

Who is running the clinical trial?

Physician Recommended NutriceuticalsLead Sponsor
4 Previous Clinical Trials
292 Total Patients Enrolled
Bradley Williams, MDPrincipal InvestigatorSouthern Eye Associates
1 Previous Clinical Trials
2 Total Patients Enrolled
~14 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top